Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
· cnbc.com · popularity 48/100 · 0 similar stories today · Sleep & Rest (Wellness, Fitness & Nutrition)
Read the original at cnbc.com →
Summary
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
Found in: News, CNBC Top News. Rating basis: single outlet; outlet tier 5; 2 feeds; listed 2 times; feed position 5.